Kura Oncology, Inc. is a company in the U.S. stock market and it is a holding in 32 U.S.-traded ETFs. KURA has around 4.0M shares in the U.S. ETF market. The largest ETF holder of KURA is the iShares Russell 2000 ETF (IWM), with approximately 1.14M shares. Investors may also find of interest that the ETF with the largest allocation to KURA stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 0.79%. On average, U.S. ETFs allocate 0.13% of KURA to their portfolios.

Additionally, KURA is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with KURA as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 50.29%.